DRKS00033529招募中Unknown
Open- label placebo effects in adolescents: Anexperimental investigation of placebo effects on sadness
Justus-Liebig-Universität Giessen, FB 06, Abteilung Klinische Psychologie und Psychotherapie0 个研究点目标入组 84 人开始时间: 2024年2月23日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 84
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 12 Years 至 17 Years（—）
- 性别
- All
入选标准
- •German speaking, no current diagnosis of a mental disorder known (self-report of parents)
排除标准
- •Reported current mental disorder, allergies against ingredients of the placebo, acute operation or injury to the nose, asthma
研究者
相似试验
已完成
不适用
Efficacy of Open Label Placebo in Children With FGIDsFunctional Abdominal PainIrritable Bowel SyndromeFunctional DyspepsiaFunctional Gastrointestinal DisordersNCT02389998Boston Children's Hospital31
已完成
不适用
Effect of open-label placebos on health status in patients with painful knee joint arthrosis - a randomized controlled trialchronic knee pain in knee joint arthrosis (Kellgren II - III)DRKS00015191Institut für Medizinische Psychologie, LMU München60
进行中（未招募）
1 期
PROPHYLAXIS STUDY OF PF-06741086 IN ADOLESCENT AND ADULT HEMOPHILIA PATIENTS WITH OR WITHOUT INHIBITORSHemophilia A or BMedDRA version: 20.0Level: LLTClassification code 10060613Term: Hemophilia A (Factor VIII)System Organ Class: 100000004850MedDRA version: 20.0Level: LLTClassification code 10060612Term: Hemophilia ASystem Organ Class: 100000004850MedDRA version: 20.0Level: LLTClassification code 10060614Term: Hemophilia B (Factor IX)System Organ Class: 100000004850EUCTR2018-003660-31-IEPfizer Inc.145
进行中（未招募）
1 期
PROPHYLAXIS STUDY OF PF-06741086 IN ADOLESCENT AND ADULT HEMOPHILIA PATIENTS WITH OR WITHOUT INHIBITORSHemophilia A or BMedDRA version: 20.0Level: LLTClassification code 10060613Term: Hemophilia A (Factor VIII)System Organ Class: 100000004850MedDRA version: 20.0Level: LLTClassification code 10060612Term: Hemophilia ASystem Organ Class: 100000004850MedDRA version: 20.0Level: LLTClassification code 10060614Term: Hemophilia B (Factor IX)System Organ Class: 100000004850EUCTR2018-003660-31-HRPfizer Inc., 235 East 42nd Street, New York, NY 10017145
进行中（未招募）
1 期
PROPHYLAXIS STUDY OF PF-06741086 IN ADOLESCENT AND ADULT HEMOPHILIA PATIENTS WITH OR WITHOUT INHIBITORSEUCTR2018-003660-31-FRPfizer Inc., 235 East 42nd Street, New York, NY 10017106